COVID-19, asthma, and biological therapies: What we need to know

Morais‐Almeida, M.; Aguiar, R.; L. Martin, Bryan; Ansotegui, I.; Ebisawa, M.; Arruda, L.; Caminati, M.; W. Canonica, G.; Carr, T.; Chupp, G.; Corren, J.; Dávila, I.; Park, Hae‐Sim; Hanania, N.; Rosenwasser, L.; Sánchez-Borges, M.; Virchow, J.; Yáñez, A.; Bernstein, J.; Caraballo, L.; Chang, Yoon-Seok; Chikhladze, M.; Fiocchi, A.; González-Díaz, S.; Tanno, L.; Levin, M.; A. Ortega-Martell, J.; Passalacqua, G.; Peden, D.; Rouadi, P.; Sublett, J.; Wong, G.; Bleecker, E.

doi:10.1016/j.waojou.2020.100126

Public

COVID-19, asthma, and biological therapies: What we need to know

Shared by NobleBlocks on May 1, 2020 • 12:00 AM UTC

Authors:

M. Morais‐Almeida

R. Aguiar

Bryan L. Martin

Abstract

Managing patients with severe asthma during the coronavirus pandemic and COVID-19 is a challenge. Authorities and physicians are still learning how COVID-19 affects people with underlying diseases, and severe asthma is not an exception. Unless relevant data emerge that change our understanding of th...

Subject

Medicine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!